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Abstract
Background: Interscalene block (ISB) is commonly performed using 20-40 mL of local anesthetic. Spread to
adjacent structures and consequent adverse effects including paralysis of the ipsilateral hemidiaphragm are
frequent. Pain ratings, analgesic requirements, adverse events, satisfaction, function and diaphragmatic excursion
were compared following interscalene block (ISB) with reduced initial bolus volumes.
Methods: Subjects undergoing arthroscopic rotator cuff repair were randomized to receive 5, 10, or 20 mL
ropivacaine 0.75% for ISB in a double-blind fashion (N = 36). Continuous infusion with ropivacaine 0.2% was
maintained for 48 h. Pain and diaphragmatic excursion were assessed before block and in the recovery unit.
Results: Pain ratings in the recovery room were generally less than 4 (0-10 NRS) for all treatment groups, but a
statistically significant difference was noted between the 5 and 20 mL groups (NRS: 2.67 vs. 0.62 respectively; p =
0.04). Pain ratings and supplemental analgesic use were similar among the groups at 24 h, 48 h and 12 weeks.
There were no differences in the quality of block for surgical anesthesia. Dyspnea was significantly greater in the
20 mL group (p = 0.041). Subjects with dyspnea had significant diaphragmatic impairment more frequently
(Relative risk: 2.5; 95%CI: 1.3-4.8; p = 0.042). Increased contralateral diaphragmatic motion was measured in 29 of
the 36 subjects. Physical shoulder function at 12 weeks improved over baseline in all groups (baseline mean SST:
6.3, SEM: 0.6; 95%CI: 5.1-7.5; 12 week mean SST: 8.2, SEM: 0.46; 95%CI: 7.3-9.2; p = 0.0035).
Conclusions: ISB provided reliable surgical analgesia with 5 mL, 10 mL or 20 mL ropivacaine (0.75%). The 20 mL
volume was associated with increased complaints of dyspnea. The 5 mL volume was associated with statistically
higher pain scores in the immediate postoperative period. Lower volumes resulted in a reduced incidence of
dyspnea compared to 20 mL, however diaphragmatic impairment was not eliminated. Compensatory increases in
contralateral diaphragmatic movement may explain tolerance for ipsilateral paresis.
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Arthroscopic shoulder surgery is known to be a particu-
larly painful stimulus that historically has often required
postoperative hospitalization for intravenous opioid
analgesia. Improvements in postoperative analgesia have
permitted these procedures to be performed in the
ambulatory setting [1]. Consequently, interscalene block
(ISB) with continuous interscalene infusion of ropiva-
caine using pumps has become standard care following
shoulder surgery at some centers.
Typically, relatively large boluses of local anesthetic
(20-40 mL) are used to initiate the ISB and a continuous
infusion of local anesthetic is then added to maintain
analgesia. This approach, while effective from an analge-
sic perspective, is associated with a number of adverse
effects. The close proximity of the phrenic nerve, recur-
rent laryngeal nerve, sympathetic chain, and other por-
tions of the brachial plexus serving the distal extremity
predispose patients to transient unwanted diaphragmatic
paresis, dysphonia, dysphagia, Horner’s syndrome (mio-
sis, ptosis, enophthalmos) with conjunctival injection
and nasal congestion, and hand numbness/weakness.
While these annoying effects are usually tolerated, they
occasionally result in hospitalization for symptom con-
trol. Patients with pre-existing pulmonary conditions
may not tolerate the sympathectomy or the diaphrag-
matic paralysis, both of which may occur in more than
80% of subjects [2]. Respiratory compromise or poor
pain control are the most common reasons for unsched-
uled hospitalization. Although reducing the initial local
anesthetic bolus from 40 ml to 20 mL in one study still
resulted in a 100% incidence of diaphragmatic paralysis
[3], decreasing the initial bolus further may result in
reduced spread to adjacent neural structures and poten-
tially fewer adverse effects [4]. The reduced mass of
local anesthetic also has the added safety benefit of
reducing the potential for local anesthetic toxicity.
The objective of this study was to examine the effect
of lower initial bolus volumes of local anesthetic on
analgesia when using ISB with continuous infusion fol-
lowing arthroscopic shoulder surgery. We hypothesized
that lower initial boluses of local anesthetic might result
in fewer adverse effects, without adversely impacting the
conduct of surgery, additional anesthesia required, or
surgical outcome.
Methods
The specific aims were to: 1) compare pain ratings and
supplemental analgesic requirements at discharge from
PACU (post anesthesia care unit; recovery room), 24
hours, and 48 hours and 12 weeks following 5, 10, and
20 mL boluses; 2) compare symptomatic adverse events
including clinical dysphonia, Horner’ss y n d r o m ea n d
dyspnea, as well as unexpected hospitalization, evidence
of local anesthetic toxicity, and perceived hand weakness
at discharge from PACU following 5, 10, and 20 mL
boluses; 3) compare impairment in diaphragmatic excur-
s i o na td i s c h a r g ef r o mP A C Uf o l l o w i n g5 ,1 0 ,a n d2 0
mL boluses; 4) compare patients’ satisfaction with
analgesia at 24 and 48 hours following 5, 10, and 20 mL
boluses; 5) compare patient rating of functional outcome
at baseline and at 12 weeks following 5, 10, and 20 mL
boluses; and 6) compare the rates of general anesthesia
required due to inadequate block following 5, 10, and
20 mL boluses.
After IRB approval from the William Beaumont
Human Investigation Committee, subjects aged 18-80
years undergoing arthroscopic shoulder surgery were
randomized into 3 groups to receive ISB with a 5, 10 or
20 mL initial bolus of ropivacaine 0.75% (http://clinical-
trials.gov. identifier: NCT00672100). The subjects were
eligible for enrollment if they were ASA risk class I-III.
Exclusion criteria were opioid tolerance, defined as > 40
mg oxycodone equivalent daily over 2 weeks prior to
study, significant preexisting pulmonary disease includ-
ing diaphragmatic paralysis or history of phrenic nerve
injury, hypersensitivity to opioids or ropivacaine, known
or suspected history of alcohol or drug abuse or depen-
dence within the previous 2 years, history of liver dis-
ease, or participation in another clinical study within 30
days of surgery. Written informed consent was obtained
from all subjects. Subjects and observers were blinded
as to group assignment.
Randomization was provided to the research pharma-
cist by a biostatistician who used a rotating block tech-
nique. The research pharmacist provided the specific
patient allocation information directly to the unblinded
anesthesiologist immediately prior to the procedure.
Unblinded investigators then administered the anes-
thetic injection and established a continuous infusion
through an interscalene catheter in the preoperative
holding area. In the operating room the quality of the
block was assessed by blinded investigators at the time
of surgical manipulation. An inadequate block was
defined as either intolerance to preoperative manipula-
tion of the shoulder by the surgeon or failure to demon-
strate hypesthesia to pinprick over the C5 and C6
dermatomes as assessed by the blinded anesthesiologist.
Sedation with intravenous propofol was then established.
Patients with failed blocks and those who were consid-
ered intolerant to the positioning (sitting with the head
in a restraint device) were provided general anesthesia
according to standard practice with propofol for induc-
tion, a laryngeal mask airway (LMA) and sevoflurane for
anesthetic maintenance. Supplemental postoperative
analgesia was provided per patient request in the PACU
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intravenous ketorolac (30 mg, one time dose), with oral
hydrocodone/acetaminophen (5/500 mg orally every 4
hours as needed) as second-line therapy prior to dis-
charge. A disposable infusion device (Pain Pump II,
Stryker, Kalamazoo, MI, USA) was used for continuous
infusion with the following settings: ropivacaine 0.2%;
bolus: 3 mL; continuous infusion: 4 mL/h; lock-out: 20
minutes. A single dose of dexamethasone was allowed
for postoperative nausea and vomiting (PONV) or
PONV prophylaxis.
Interscalene block
Ultrasound-guided placement (high frequency probe;
10-12 Hz) of an ISB and catheter was performed at
the ipsilateral upper truck or C5 root, usually near a
point midway between lines extending laterally from
the cephalad border of the thyroid cartilage and from
the cricoid cartilage, between the anterior and middle
scalene muscles. Following penetration of the fascial
sheath, observation of spread of 1 mL normal saline
circumferentially surrounding the most cephalad nerve
of the plexus confirmed correct placement in an out-
of-plane view. The initial block was placed though the
needle (18G Contiplex
®,B .B r a u nM e d i c a lI n c . ,B e t h -
lehem, PA, USA) prior to insertion of a non-stimulat-
ing 20 gauge nylon catheter. The interscalene
catheters were advanced exactly 2 cm in all cases. The
catheter used has a closed end with 3 orifices located
5, 10 and 15 mm from the tip. A standardized contin-
uous infusion was started immediately after catheter
placement.
Outcome measures
After discharge home directly from the PACU, patients
were contacted by telephone to collect outcome data at
24 hours, 48 hours, and 12 weeks postoperatively using
a structured interview.
Pain measurements
Categorical and Numeric Pain Rating Scales (NRS) were
recorded at baseline (pre-operatively), at discharge from
PACU, and at 24 and 48 hours. The primary efficacy
outcome was the NRS pain score at discharge from
PACU. Other pain assessments were secondary end-
points. A change in NRS of 1.8 was considered clinically
significant [5].
Diaphragmatic excursion
Diaphragmatic excursion at maximal effort for inspira-
tion and exhalation was assessed by a blinded ultrasono-
grapher bilaterally, both preoperatively and prior to
discharge from PACU, using a low frequency probe (4
Hz) posterolaterally as described by Borgeat et al [6]. A
50% reduction in ipsilateral diaphragmatic motion com-
pared to baseline was considered clinically meaningful
and represented the primary safety outcome measure.
Because diaphragmatic excursion may decrease as a
result of surgery, anesthesia, and opioid pain medica-
tions, the change in ipsilateral measurement was also
compared to alterations in contralateral diaphragmatic
motion.
Additional secondary outcome measures
Dyspnea
At discharge from PACU, 24 and 48 hours patients were
asked “Do you feel short of breath or are you having
trouble catching your breath?” (yes/no)
Subjective dysphonia
At discharge from PACU, 24 and 48 hours patients were
asked “Is your voice hoarse?” (yes/no)
Symptomatic horner’s syndrome
At discharge from PACU, 24 and 48 hours patients were
asked “Do you have blurred vision or a droopy eyelid?”
If either of these effects were noted the patient was con-
sidered to have symptomatic Horner’sS y n d r o m ea n da
positive finding (yes/no) was recorded.
Perceived hand weakness
At discharge from PACU, 24 and 48 hours grip strength
was assessed by asking the question, “Does your grip
feel weak?” (yes/no)
Patient satisfaction
A 24 and 48 hours the 5-point Likert categorical Help-
fulness Scale was administered ("Is your interscalene
infusion: extremely harmful; harmful; neutral: not harm-
ful, but not helpful; helpful; extremely helpful?”)
Functional outcome
At baseline and again at 12 weeks subjects completed
the Simple Shoulder Test. This test is a series of 12
(yes/no) questions. This hasb e e ns h o w nt ob eav a l i d ,
reliable and consistent for subjects up to and including
60 years of age when similar injuries (rotator cuff dys-
function) are assessed [7]. The use of this assessment
collected by telephone interview [8] has been validated
and is comparable to more complicated scales when
converted to a 100-point scale [9].
Local anesthetic toxicity
At discharge from PACU, 24 and 48 hours the presence
of any one of the following was considered a positive
score: tinnitus, perioral numbness, feeling jittery (yes/no)
Other
Unscheduled admission, total amount of local anesthetic
used (read directly from the pump), type and amount of
supplemental analgesics, nausea/vomiting, requirement
for general anesthesia (defined as the use of a laryngeal
mask airway and/or inhalational anesthesia, i.e. sevoflur-
ane), early termination (catheter malfunction/dislodge-
ment prior to 48 hours) were recorded.
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Sample size for efficacy was determined by considering
the equivalence of two means based on means and stan-
dard deviations from data previously collected as part of
routine quality assurance monitoring and a minimum
clinically significant difference for NRS pain at discharge
from PACU of 1.8. Twelve subjects per group (N = 36)
would yield 90% power at the 0.05 significance level.
Power analysis for primary safety outcome (proportion
of subjects with significant reductions in diaphragmatic
excursion) using a 30% difference from expected out-
come (5 mL vs. 20 mL) with 12 subjects in each group
provided 90% power at the 0.01 significance level.
For each bolus group, most outcomes were measured
repeatedly over time. Therefore, measurements obtained
from a patient in each group over time were not inde-
pendent. Continuous outcomes measured at only one
time point were compared across the three bolus groups
using either a one-way analysis of variance or a Kruskal-
Wallis test depending on whether the response is nor-
mally or non-normally distributed respectively. Categori-
cal outcomes were compared among the three bolus
groups using either the Fisher’sE x a c to rC h i - S q u a r e
tests. Continuous outcomes measured at exactly two
time-points were analyzed by first computing the paired
differences (accounting for correlation in measurements
between time points) within each bolus group and then
analyzing the differences across the three bolus groups
using a one-way analysis of variance or a Kruskal-Wallis
test depending on whether the paired differences is nor-
mally or non-normally distributed respectively. Categori-
cal outcomes were analyzed using the Cochran-Mantel-
Haenszel statistics stratified by the bolus groups.
Continuous and categorical outcomes measured at
more than two time-points were analyzed in the follow-
ing manner: Normally and non-normally distributed
outcomes measured were analyzed using generalized lin-
ear mixed models (GLMM), nonlinear mixed models
(NLMM), general linear models (GLM), or nonlinear
models (NLM) depending on whether the errors are
correlated and/or the presence of random effects, and/
o rt h ep r e s e n c eo fn o n l i n e a r i t y .T om a k et h ea n a l y s i s
more sensitive to individual variations, baseline outcome
measurements were used as covariates in these analyses
thereby altering all of these models to analyses of covar-
iance (ANCOVA). All of the data were analyzed on an
intent-to-treat principle using SAS JMP 8.0.
Additionally, all outcome measures were first analyzed
using numerical and graphical techniques to determine
their distributions. Based on this preliminary assessment,
parametric, nonparametric, or exact statistical tests were
used. Functional outcomes based on the Simple
Shoulder Test were first scored according to the pre-
viously mentioned algorithm [9]. Any subscales
generated based on this algorithm were then be used in
the analysis instead of the individual items.
Results
Sixty-nine subjects were screened; from January 2009
through December 2009, 36 subjects were randomized
into the study (Figure 1). All subjects completed the
study with the exception of one subject in the 5 mL
group who was lost to follow-up for the 12-week end-
point only. All patients were managed as outpatients;
none were admitted to hospital and no patient experi-
enced a prolonged recovery stay. Demographics and
baseline pain scores were similar among all three groups
(Table 1).
Pain ratings and supplemental analgesic use were gen-
erally similar among the groups at 24 h, 48 h and 12
weeks (Table 2). While the mean pain scores at all time
points and for all groups were less than 4 (0-10; NRS), a
statistically significant difference in pain at discharge
was noted when comparing the 5 mL group to the 20
mL group (NRS: 2.67 vs. 0.62 respectively; p = 0.04).
Supplemental opioid was numerically greater in the first
24 hours in the 5 and 10 mL groups compared to the
20 mL group, but this difference was not statistically sig-
n i f i c a n t( T a b l e3 ) .T h eu s eo ft h ep a t i e n t - c o n t r o l l e d
regional analgesia, as measured by the total ropivacaine
administered via the pump, was also similar among all 3
groups over the first 48 hours.
There were no differences in the quality of block for
surgical anesthesia. This determination was made by the
blinded anesthesiologist prior to surgery. Allocation had
no effect on type of anesthesia used: the majority had
sedation only (n = 15) or GA per surgeon request for
positioning (n = 17). Inadequate analgesia, as deter-
m i n e db yt h eb l i n d e da n e s t h e s i o l o g i s tp r i o rt os u r g e r y ,
requiring GA was not significantly different among
groups (5 mL: n = 1; 10 mL: n = 2; 20 mL: n = 1). No
patient was converted from sedation to GA.
The subjective sensation of dyspnea in the PACU was
significantly greater in the 20 mL group (5 mL: 1 (8.3%);
10 mL: 0 (0%); 20 mL 4 (33%); Likelihood ratio 6.4, p =
0.041). While mean reductions in ipsilateral diaphragm
motion were noted following interscalene block in all
groups (Table 4), independent of dose, subjects with
dyspnea frequently exhibited clinically meaningful ipsi-
lateral diaphragmatic impairment (Relative risk: 2.5; 95%
CI: 1.3-4.8; p = 0.042). All subjects reporting dyspnea
had Body Mass Indices greater than 30. The subject
with dyspnea in the 5 mL group had a BMI of 31; the
subjects in the 20 mL group had BMIs of 31, 32, 33,
and 33. However, there was no direct correlation gener-
ally between BMI and dyspnea. Moreover, there was an
increase in contralateral diaphragmatic excursion noted
in 29 of the 36 subjects (Table 4). Analysis of covariates
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Allocated to 5 mL (N=12) 
     Received intervention (n=12) 
     Did not receive intervention (n=0) 
Allocated to 10 mL (N=12) 
     Received intervention (n=12) 
     Did not receive intervention (n=0) 
Allocated to 20 mL (N=12) 
     Received intervention (n=12) 
     Did not receive intervention (n=0) 
Lost to follow-up (N=1) 
     Discontinued intervention (n=0) 
     Other (n=1) 
  Did not return 12 week call 
Lost to follow-up (N=0) 
     Discontinued intervention (n=0) 
     Other (n=0) 
Lost to follow-up (N=0) 
     Discontinued intervention (n=0) 
     Other (n=0) 
Analyzed (N=12), acute;  
(N=11, 12 week) 
     Excluded from analysis (n=0), acute; 
 (n=1,  12  week) 
Analyzed (N=12) 
     Excluded from analysis (n=0) 
Analyzed (N=12) 
     Excluded from analysis (n=0) 
Assessed for Eligibility 
N=69 
Excluded (N=33) 
     Not meeting inclusion criteria (n=2) 
     Met exclusion criteria (n=6) 
     Refused to participate (n=12) 
     Other reasons (n=13) 
Randomized (N=36) 
Figure 1 CONSORT diagram.
Table 1 Demographics and Baseline Evaluations
5 mL (N = 12) 10 mL (N = 12) 20 mL (N = 12) P value
Age (mean in yr ± SEM; 95%CI) 51 ± 4; 42-60 55 ± 3.7; 46-63 50.5 ± 3.3; 43-58 > 0.72
Sex (M/F) 7/5 9/3 9/3 > 0.78
BMI(mean in kg/m
2 ± SEM; 95%CI) 29 ± 2; 25-33.4 28 ± 0.9; 26-30 29 ± 1.9; 25-33 > 0.82
ASA status (1/2/3) 2/8/2 0/12/0 3/8/1 > 0.512
Baseline Pain (median NRS: 0-10; 95%CI) 2; 0.7-4.5 2; 0.6-2.6 2; 0.8-2.3 > 0.52
Dominant hand (R/L) 12/0 10/2 11/1 > 0.22
Operative side (R/L) 9/3 7/5 7/5 > 0.52
Baseline Function (SST median; 95%CI) 7; 4.5-9.5 5; 3.5-7.8 7; 4.2-8.4 > 0.50
Baseline diaphragmatic excursion: right (mean ± SEM; 95%CI) 4.5 ± 0.7; 3.0-6.0 4.5 ± 0.6; 3.1-5.9 4.6 ± 0.7; 3.1-6.1 > 0.90
Baseline diaphragmatic excursion: left (mean ± SEM; 95%CI) 4.1 ± 0.5; 3.0-5.2 4.5 ± 0.5; 3.4-5.7 4.2 ± 0.4; 3.3-5.1 > 0.81
SEM: Standard Error of the Mean; 95%CI: 95% Confidence Interval; BMI: Body Mass Index; ASA: American Society of Anesthesiologists; NRS: numeric rating scale;
SST: Simple Shoulder Test
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Page 5 of 8failed to find a clinically meaningful correlation between
the degree of ipsilateral reduction in hemidiaphragm
excursion and the increase in contralateral function.
None of the patients experienced significant oxygen
desaturation requiring intervention or resulting in a pro-
longed recovery time. Other adverse effects were also
similar among groups. There were no unscheduled
admissions or early terminations.
Patient satisfaction was high in all groups at both 24
and 48 hours. The majority of subjects considered the
analgesic technique to be either “helpful” or “extremely
helpful” at 24 and 48 hours respectively in the 5 mL
group (83%; 83%), the 10 mL group (83%; 75%), and the
20 mL group (92%; 85%). There were no statistically sig-
nificant differences in satisfaction among groups. Surgi-
cal outcome, as assessed by the SST, improved similarly
and significantly in all groups (baseline mean SST: 6.3,
SEM: 0.6; 95%CI: 5.1-7.5; 12 week mean SST: 8.2, SEM:
0.46; 95%CI: 7.3-9.2; p = 0.0035).
Discussion
Interscalene block provides an effective method for both
surgical anesthesia and postoperative analgesia in
shoulder surgery. While injection of relatively large
volumes of local anesthetic may increase the duration of
anesthesia, perhaps by providing a reservoir effect,
spread of local anesthetic away from the plexus (as
occurs with a large bolus of medication injected over a
relatively short period of time) results in unwanted
blockade of other neural structures in the cervical
region, including the phrenic nerve or its constituent
n e r v er o o t s .I nas t u d yb yR i a z ie ta l .e x a m i n i n gd i a -
phragmatic function following interscalene block com-
paring 5 mL to 20 mL injection of ropivacaine 0.5%,
significantly fewer subjects experienced diaphragmatic
paresis in the lower volume group [10]. This sparing
effect was accompanied by a blunting of impairments in
FVC and oxygen saturation without a reduction in post-
operative analgesia. However, lower amounts of local
anesthetic (reduced mass of drug), while satisfactory for
postoperative analgesia, could potentially result in
diminished effectiveness of the quality of surgical
anesthesia. Since all subjects were provided general
anesthesia for their operative procedure, whether the
low volume injections would have been adequate for
surgery is unknown.
A recent report comparing ISB at the C6 level with 10
mL to 20 mL also found no difference in postoperative
analgesia duration or quality [11]. However, as in the
Riazi et al. study, all subjects were given a general anes-
thetic, including neuromuscular blockade. In contrast to
Riazi et al., injection of the lower volume (10 mL as
opposed to 5 mL) did not result in sparing of diaphrag-
matic function. In the present study, when ISB was per-
formed with US-guidance directed at the C5 level,
reliable surgical anesthesia was achieved with 5 mL ropi-
vacaine (0.75%) for shoulder arthroscopy for rotator cuff
repair. The requirement for general anesthesia due to
inadequate blockade was low and similar in all groups.
Even though the assessment as to the quality of block
was made by a blinded anesthesiologist before sedation
was given, the fact that GA was allowed as an option is
a limitation of the study. No subjects were converted
from sedation to GA and no patients required neuro-
muscular blockade. The use of a higher concentration of
local anesthetic (0.75% vs. 0.5%) in this study may have
contributed to the quality of block for surgical
anesthesia.
Although the pain scores on discharge from the recov-
ery room were numerically higher in the 5 mL group
compared to the 20 mL group, clinically all pain scores
remained low and were well tolerated, perhaps as a
Table 2 Postoperative Pain [mean NRS (SE); 95%CI]
Allocation Discharge 24 h 48 h 12 weeks
5 mL 2.67 (0.93); 0.61-4.71* 3.67 (0.74); 2.03-5.30 2.67 (0.72); 1.08-4.25 1.5 (0.45); 0.50-2.50
10 mL 1.58 (0.80); -0.18-3.35 3.33 (0.80); 1.57-5.10 2.08 (0.65); 0.66-3.50 2.42 (0.85); 0.55-4.28
20 mL 0.62 (0.40); -0.26-1.49* 2.54 (0.67); 1.09-3.99 2.15 (0.56); 0.92-3.38 1.15 (0.34); 0.42-1.89
NRS: numeric rating scale; SE: Standard Error; 95%CI: 95% Confidence Interval * p = 0.04 for 5 mL compared to 20 mL only; for all other comparisons p > 0.05
Table 3 Postoperative analgesics [mean (SE); 95%CI]**




cumulative ropivacaine infusion 0-24 h
(mL)
cumulative ropivacaine infusion 0-48 h
(mL)
5 mL 27.7 (8.4); 8.9-46.5 18.9 (6.2); 3.7-34.1 111.3 (8.0); 93.7-128.9 210.8 (16.9); 173.6-248.0
10 mL 29.8 (8.2); 11.9-47.7 16.4 (3.5); 8.4-24.4 131.6 (12.4); 104.4-158.8 236.1 (9.9); 214.3-257.9
20 mL 13.4 (1.7); 9.6-17.3 21.3 (4.1); 12.3-30.3 113.0 (4.9); 102.4-123.6 219.8 (10.9); 196.0-243.5
SE: standard error; 95%CI: 95% confidence interval
* converted to equivalent oral morphine (mg)
**p > 0.05 for all comparisons
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the supplemental opioid in both the 5 mL and 10 mL
groups compared to the 20 mL group over the first 24
hours. Others have reported satisfactory postoperative
analgesia with volumes even lower than 5 mL.
McNaught et al. reported that the use of ultrasound for
interscalene block allowed the mean effective volume of
local anesthetic for adequate postoperative analgesia in
the immediate recovery period to be reduced to 0.9 mL
compared to 5.4 mL when using nerve stimulation [12].
Similar findings were reported by Renes et al. where the
minimum effective volume of 0.75% ropivacaine was 2.9
ml in 50% of patients and 3.6 mL in 95% of patients
[13]. The postoperative analgesia with the 5 mL volume
for interscalene block in the present study was less
impressive; the difference in mean NRS in the PACU
between the 5 mL and 20 mL groups was greater than
the prespecified 1.8 point differential defined as a clini-
cally significant change in pain scores. However, with
mean NRS scores for pain less than 3, it did not trans-
late into delayed discharge, lower satisfaction, or statisti-
cally higher supplemental opioid. Clinically the quality
of postoperative analgesia could potentially be improved
by repeating a small volume injection through the inter-
scalene catheter at the conclusion of surgery or in the
recovery room without risking the widespread distribu-
tion associated with a large initial bolus. Despite these
differences, patient satisfaction with the quality of post-
operative analgesia was high and similar in all groups.
While no subjects required admission to hospital, the
20 mL volume was associated with increased subjective
complaints of dyspnea consistent with a previous report
[10]. However, in contrast to their results [10] and the
results of Renes et al. [13], the use of lower volume (5
m L )d i dn o tr e s u l ti nc o n s i s t e n ts p a r i n go fd i a p h r a g -
matic function. Whether this was the result of the use
of a higher concentration (0.75% versus 0.5%) [10] and
thus a larger mass of drug, or the precise placement at
C5, as opposed to a lower placement adjacent to the C6
[10] or C7 [13] cannot be determined from this study. It
is likely that even small precisely placed volumes of
local anesthetic, when placed at C5, can spread proxi-
m a l l yt oa f f e c tt h ep h r e n i cn e r v e( C 4 , 5 )f u n c t i o ne v e n
when there is no spread anterior to the anterior inter-
scalene muscle. Spread to the sympathetic chain with
subsequent Horner’s Syndrome was evaluated only on a
symptomatic basis. Larger initial injectate volumes,
while inducing more objective evidence of Horner’s Syn-
drome preoperatively, did not result in increased subjec-
tive complaints in the postoperative period. This effect
was therefore considered well tolerated in patients with-
out preexisting respiratory compromise or asthma.
A compensatory increase in contralateral diaphrag-
matic movement could account for the relative tolerance
for unilateral paresis in otherwise healthy subjects with-
out preexisting respiratory disease. However, the degree
of compensation did not correlate well with the degree
of ipsilateral paresis. This suggests the involvement of
other covariants. All patients in this study with subjec-
tive complaints of dyspnea were obese. It seems reason-
able that an increased BMI could play a role in the
reduced ability to effectively increase the excursion of
the contralateral hemidiaphragm. Yet a clear inverse
relationship between BMI and contralateral diaphrag-
matic compensation was not observed. Consequently,
while obesity could be one risk factor, since other obese
subjects did not develop dyspnea, it seems not to be suf-
ficient as the sole risk factor. The study was not suffi-
ciently powered to further evaluate this effect.
Conclusions
As the highest dose was associated with increased dys-
pnea, absent improvement in surgical anesthesia or sig-
nificantly improved subsequent analgesia, function, or
satisfaction scores, the 20 mL initial bolus cannot be
routinely recommended. This recommendation may be
especially valid when an interscalene catheter is placed,
thus allowing additional incremental local anesthetic
injections to be titrated to control postoperative pain.
While the 5 mL initial bolus generally provided ade-
quate analgesia in the PACU, it was associated with sta-
tistically higher pain scores and a trend towards greater
opioid consumption compared to the 20 mL group.
This suggests that the 5 mL group, having no advantage
over the 10 mL group with respect to reduced adverse
effects, might be near the lower limit of clinical accept-
ability. Lower concentrations of local anesthetic might
further reduce complaints of dyspnea, however the effect
on the quality of surgical anesthesia when using a lower
mass of drug has not been evaluated.
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